Inbios International, Inc.
Publicly observedSeattle, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Seattle | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Inbios International, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CNJNQ1GMSN55 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant8 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of a sensitive Point-of-Care immunoassay for tick- borne spotted fever group rickettsioses
USD 314,363.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 May 2024Publicly observed
NIH SBIR/STTR award: Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease
USD 974,356.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 May 2024Publicly observed
NIH SBIR/STTR award: Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease
USD 988,977.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.